Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3MKS

Crystal Structure of yeast Cdc4/Skp1 in complex with an allosteric inhibitor SCF-I2

Summary for 3MKS
Entry DOI10.2210/pdb3mks/pdb
Related1NEX
DescriptorSuppressor of kinetochore protein 1, Cell division control protein 4, SULFATE ION, ... (6 entities in total)
Functional Keywordsubiquitin ligase, protein binding, small molecule complex, ligase/cell cycle, ligase-cell cycle complex
Biological sourceSaccharomyces cerevisiae (brewer's yeast,lager beer yeast,yeast)
More
Total number of polymer chains4
Total formula weight146224.45
Authors
Orlicky, S.,Sicheri, F.,Tyers, M.,Tang, X. (deposition date: 2010-04-15, release date: 2010-07-21, Last modification date: 2023-09-06)
Primary citationOrlicky, S.,Tang, X.,Neduva, V.,Elowe, N.,Brown, E.D.,Sicheri, F.,Tyers, M.
An allosteric inhibitor of substrate recognition by the SCF(Cdc4) ubiquitin ligase.
Nat.Biotechnol., 28:733-737, 2010
Cited by
PubMed Abstract: The specificity of SCF ubiquitin ligase-mediated protein degradation is determined by F-box proteins. We identified a biplanar dicarboxylic acid compound, called SCF-I2, as an inhibitor of substrate recognition by the yeast F-box protein Cdc4 using a fluorescence polarization screen to monitor the displacement of a fluorescein-labeled phosphodegron peptide. SCF-I2 inhibits the binding and ubiquitination of full-length phosphorylated substrates by SCF(Cdc4). A co-crystal structure reveals that SCF-I2 inserts itself between the beta-strands of blades 5 and 6 of the WD40 propeller domain of Cdc4 at a site that is 25 A away from the substrate binding site. Long-range transmission of SCF-I2 interactions distorts the substrate binding pocket and impedes recognition of key determinants in the Cdc4 phosphodegron. Mutation of the SCF-I2 binding site abrogates its inhibitory effect and explains specificity in the allosteric inhibition mechanism. Mammalian WD40 domain proteins may exhibit similar allosteric responsiveness and hence represent an extensive class of druggable target.
PubMed: 20581844
DOI: 10.1038/nbt.1646
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.6 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon